首页> 外文期刊>Expert Review of Ophthalmology >Ocular surface reconstruction: recent innovations, surgical candidate selection and postoperative management
【24h】

Ocular surface reconstruction: recent innovations, surgical candidate selection and postoperative management

机译:眼表重建:最新创新,手术候选者的选择和术后管理

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Intricate homeostasis maintains the rich complexity and functionality of the ocular surface. Severe ocular surface diseases cause significant morbidities, including blindness. Ocular surface reconstruction strategies restore this homeostasis. Patients with limbal deficiency may benefit from limbal stem cell transplantation to alleviate persistent epithelial defects, maintain conjunctivalization regression and corneal avascularity, and restore vision. Amniotic membrane and other substrates function as tissue surrogates and substrates for expansion of stem cells. Maximum graft survivability necessitates aggressive and comprehensive preoperative management of inflammation, infection, microtrauma, dry eye conditions and HLA compatibility. Restoration of lacrimal gland function is important, as is implementation of aggressive immunosuppression. Future advancements in stem cell biology, tissue engineering, bioartificial microsystems or regenerative medicine will supplement the therapeutic armamentarium. The next decade will be an exciting time for corneal surgeons.
机译:复杂的动态平衡保持了眼表的丰富复杂性和功能。严重的眼表疾病会导致很多疾病,包括失明。眼表重建策略可恢复这种稳态。角膜缘缺损的患者可从角膜缘干细胞移植中受益,以减轻持续存在的上皮缺损,维持结膜消退和角膜无血管性并恢复视力。羊膜和其他基质可作为组织替代物和干细胞扩增的基质。移植物的最大生存能力要求积极,全面的术前处理炎症,感染,微创伤,干眼症和HLA相容性。恢复泪腺功能很重要,积极免疫抑制的实现也很重要。干细胞生物学,组织工程,生物人工微系统或再生医学的未来发展将补充治疗性武器库。对于角膜外科医生来说,下一个十年将是令人激动的时刻。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号